Trials said to show efficacy of acrylamide inhibitor for bread
Acrylamide reductions in bread of up to 90 per cent have been claimed in initial test results announced this week for a proprietary yeast product from Phyterra Yeast, a division of Canadian firm, Functional Technologies Corporation.